Alembic Pharmaceuticals informs about press release

10 Jul 2017 Evaluate

Alembic Pharmaceuticals has informed about press release titled ‘Alembic Pharmaceuticals receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 150 mg’.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

706.80 -5.45 (-0.77%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.90
Dr. Reddys Lab 1325.50
Cipla 1329.90
Zydus Lifesciences 922.00
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×